Reviews still describe DSIP as unresolved, with unclear receptors and varied outcomes
Water, Sodium Laureth Sulfate, Centella Asiatica Extract (5.1%), Glycerin, Propylene Glycol, Cocamide MEA, Lauramide DEA, Cocamidopropyl Betaine, Glutathione (1,000ppm), Niacinamide (1,000ppm), Citric Acid, Sodium Hyaluronate, Caprylic/Capric Triglyceride, Hydrogenated Lecithin, Glyceryl Stearate, Cholesterol, Nelumbo Nucifera Extract, Artemisia Annua Extract, Oryza Sativa (Rice) Extract, Saccharomyces Ferment, Solanum Melongena (Eggplant) Fruit Extract, Melaleuca Alternifolia (Tea Tree) Leaf Extract, 1,2-Hexanediol, Hydrolyzed Collagen, Beta-Glucan, Dipropylene Glycol, Hippophae Rhamnoides Fruit Extract, Butylene Glycol, Styrene/Acrylates Copolymer, Xanthan Gum, Madecassic Acid, Asiaticoside, Asiatic Acid, Squalane, Polyquaternium-10, Disodium EDTA, Sodium Benzoate, Chlorphenesin, Sodium Chloride

SARS-CoV-2 infection exacerbates this metabolic imbalance and predisposes these patients to the severe pathophysiologies of COVID-19, including the involvement of NETs (neutrophil extracellular traps) and HA overproduction in the lung
J Psoriasis Psoriatic Arthritis (2021) 6(4):18597
After consideration of the public comments we received, we are finalizing our proposed APC assignment and status indicator for CPT code 38228 to APC 5694 without modification